subscribeSubscribe
Another ADC biotech reels in big bucks as Mark Alles’ TORL nabs $158M

Another ADC biotech reels in big bucks as Mark Alles’ TORL nabs $158M
Kyle LaHucik ENDPTS
10 Apr 2024
Share Share
BMS accused of anticompetitive tactics to keep Pomalyst chugging

BMS accused of anticompetitive tactics to keep Pomalyst chugging
Zoey Becker FIERCE PHARMA
07 Sep 2023
Share Share
NICE recommends combination treatment for patients with multiple myeloma

NICE recommends combination treatment for patients with multiple myeloma
PHARMAFILE
24 Dec 2021
Share Share
Supreme Court won`t hear bid to challenge thalidomide settlement

Supreme Court won`t hear bid to challenge thalidomide settlement
CTVNEWS
10 Jun 2021
Share Share
Accord Healthcare launches thalidomide for multiple myeloma treatment

Accord Healthcare launches thalidomide for multiple myeloma treatment
PHARMAFILE
23 Mar 2021
Share Share
E.C Approves Darzalex, Bortezomib, Thalidomide and Dexamethasone combo

E.C Approves Darzalex, Bortezomib, Thalidomide and Dexamethasone combo
BUSINESS WIRE
20 Jan 2020
Share Share
Celgene backs out of $55M class-action settlement on claims

Celgene backs out of $55M class-action settlement on claims
Eric Sagonowsky FIERCE PHARMA
10 Jan 2020
Share Share
J&J darzalex-FDA approval in frontline multiple myeloma use as Sanofi rival

J&J darzalex-FDA approval in frontline multiple myeloma use as Sanofi rival
N.Grover ENDPTS
28 Sep 2019
Share Share
Takeda suffers another setback in its quest to expand myeloma drug’s reach

Takeda suffers another setback in its quest to expand myeloma drug’s reach
John Carroll ENDPTS
06 Jun 2019
Share Share
The shrinking biotech bazaar

The shrinking biotech bazaar
NATURE BIOTECH
05 Feb 2019
Share Share